Among the 11 characteristic genes identified, HNRNPC emerged as an independent prognostic factor for OS and disease-free survival in HCC patients, and it may be related to sorafenib treatment and anti-PD-1 immunotherapy response [58]. Here, HNRNPC is linked to hepatocellular carcinoma.